Prevalence of neurocysticercosis in people with epilepsy in the Eastern Province of Zambia by Mwape, Kabemba E et al.
RESEARCH ARTICLE
Prevalence of Neurocysticercosis in People
with Epilepsy in the Eastern Province of
Zambia
Kabemba E. Mwape1☯, Joachim Blocher2,3☯*, JasminWiefek4, Kathie Schmidt5,
Pierre Dorny6, Nicolas Praet6, Clarance Chiluba7, Holger Schmidt3, Isaac K. Phiri1, Andrea
S. Winkler8‡, Sarah Gabriël6‡
1 Department of Clinical Studies, School of Veterinary Medicine, University of Zambia, Lusaka, Zambia,
2 Department of Neurology, Medical University Center Göttingen, Göttingen, Germany, 3 Department of
Neurology, Elbe-Kliniken Stade/Buxtehude GmbH, Stade, Germany, 4 Europe-University of Flensburg,
Flensburg, Germany, 5 Department of Neuroradiology, Medical University Center Göttingen, Göttingen,
Germany, 6 Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium, 7 Levy
Mwanawasa General Hospital, Lusaka, Zambia, 8 Department of Neurology, Technical University Munich,
Munich, Germany
☯ These authors contributed equally to this work.
‡ ASW and SG also contributed equally to this work.
* Joachim.blocher@med.uni-goettingen.de
Abstract
Zambia is endemic for Taenia solium taeniosis and cysticercosis. In this single-centered,
cross-sectional, community-based study, the role of neurocysticercosis (NCC) as a cause
of epilepsy was examined. People with epilepsy (PWE, n = 56) were identified in an
endemic area using a screening questionnaire followed by in-depth interviews and neuro-
logical examination. Computed tomography (CT) was performed on 49 people with active
epilepsy (PWAE) and their sera (specific antibody and antigen detection, n = 56) and stools
(copro-antigen detection, n = 54) were analyzed. The CT scan findings were compared to a
group of 40 CT scan controls. Of the PWE, 39.3% and 23.2% were positive for cysticercal
antibodies and antigens, respectively, and 14.8% for coproantigens (taeniosis). Lesions
highly suggestive of NCC were detected in 24.5% and definite NCC lesions in 4.1% of CT
scans of PWAE. This compares to 2.5% and 0%, respectively, in the control CT scans.
Using the Del Brutto diagnostic criteria, 51.8% of the PWAE were diagnosed with probable
or definitive NCC and this rose to 57.1% when the adapted criteria, as proposed by Gabriël
et al. (adding the sero-antigen ELISA test as a major criterion), were used. There was no
statistically significant relationship between NCC, current age, age at first seizure and gen-
der. This study suggests that NCC is the single most important cause of epilepsy in the
study area. Additional large-scale studies, combining a community based prevalence study
for epilepsy with neuroimaging and serological analysis in different areas are needed to esti-
mate the true impact of neurocysticercosis in endemic regions and efforts should be insti-
tuted to the control of T. solium.
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Author Summary
Neurocysticercosis, an infection caused by the larval stage of Taenia solium (the pork tape-
worm), is a preventable and treatable disease and one of the main causes of epilepsy in
low-income countries. Studies in Zambia have indicated high endemicity of T. solium in
rural communities where a high prevalence of epilepsy has been reported. It was therefore
important to analyze the role of neurocysticercosis as a cause of epilepsy. Diagnosis of the
condition, however, relies on neuroimaging techniques, which are not routinely available
in our study area. In this imaging-based study, people with epilepsy were identified, exam-
ined by a neurologist, their brains scanned using computed tomography, and their stools
and sera analyzed for specific antigens and antibodies. The study suggests that 57.1% of
these people suffered from neurocysticercosis, making it the single most important cause
of epilepsy in the study area. The results show the need to institute control measures to
alleviate the suffering of the affected communities. In summary, the recognition of neuro-
cysticercosis as an important cause of epilepsy will aid in the treatment and prevention of
epilepsy in affected communities and alleviate the burden of neurocysticercosis on the
rural people.
Introduction
Neurocysticercosis (NCC) is a parasitic infection of the brain caused by the metacestode larval
stage of the pork tapeworm Taenia solium and occurs primarily in low-income countries. Pigs
are the natural intermediate host for the tapeworm, while humans are the only definitive host
but may accidentally also serve as the intermediate host [1]. Humans become tapeworm carri-
ers (taeniosis) after ingestion of undercooked pork that is infected with cysticerci (cysticerco-
sis). Humans and pigs acquire cysticercosis after ingestion of infective eggs that are passed in
stool by a tapeworm carrier. The cysts have the propensity to localize in the brain leading to
NCC [1]. NCC can cause a wide range of neurological disorders including epileptic seizures,
headaches and focal neurological symptoms/signs [2–4]. It is reported as one of the major
causes of acquired epilepsy in endemic areas [5, 6], which has profound social, physical and
psychological consequences. Population based studies have reported that approximately 30%
of cases of epileptic seizures are attributable to NCC [7, 8].
The prevalence of epilepsy as determined in community-based studies throughout Africa
shows varying results depending on the study population and the methodologies used, ranging
from 5.2–74.4/1000 with a median of 15/1000 inhabitants [9, 10]. This is compared to high-
income countries where the prevalence of active epilepsy is estimated to be about 4–8/1000
inhabitants [11]. Epilepsy represents the most common chronic neurological disorder in sub-
Saharan Africa, and involves unprovoked recurrent (two or more) afebrile seizures that may
result in injury, disability and social stigmatization [12, 13]. For individuals with epilepsy in
many low-income countries, including Zambia, the etiology of the disease often remains
unclear.
The endemicity of T. solium infections in Zambia has been mentioned in many reports. Por-
cine cysticercosis prevalence estimates have been reported to range from 8.2–64.2% [14] while
human cysticercosis is reported to range from about 6–13% (based on circulating antigen
detection) in studies carried out in the Eastern province [15, 16]. The Eastern province harbors
almost 50% of the total number of pigs in the country, which are mostly reared under the
small-scale management system [17]. Due to the lack of sanitary facilities such as latrines, free-
ranging pigs have access to human feces. Such conditions increase the risk of both porcine
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cysticercosis and human taeniosis/cysticercosis infection. The high percentage of active cysti-
cercosis infections (12.5%), determined in a study in Katete district (Eastern province) [15],
indicates the urgent need to identify the importance of NCC as a cause of epilepsy in this area.
Therefore, the main objective of this cross-sectional study was to analyze the role of NCC as a
cause of epilepsy in a study area of Katete district of the Eastern province of Zambia.
Materials and Methods
Ethical considerations
The University of Zambia Biomedical Research Ethics Committee (IRB0001131) and the Ethi-
cal Committee of the University of Antwerp, Belgium, both granted ethical clearance for the
study (ITG:12084813). Further approval was sought from the Ministry of Health of Zambia,
from the local district health authorities and the area chief. Meetings were held with the people
in the villages through their leaders (headmen) to explain the purpose of the study, request
their permission to conduct the study and also to invite them to participate. Further permission
was sought from the individual subjects to enter the study after oral consent for the screening
questionnaires and written informed consent for further examinations. The use of oral consent
in the screening phase was explicitly approved by both ethics committees and no special docu-
mentation of the oral consent was required. For individuals below the consenting age, their
parents were asked for informed consent on their behalf. All collected samples were assigned
an identification number that was linked to the questionnaire, neurological examination, labo-
ratory test results and neuroimaging results. For neuroimaging, participants that were diag-
nosed with active epilepsy were transported to Lusaka accompanied by two medical officials
from the local rural health center. For children below the age of 16, a parent or guardian
accompanied them to Lusaka. In collaboration with the regional health center Mtandaza all
patients received free antiepileptic drugs according to national guidelines and niclosamide in
case they were diagnosed with taeniosis. Patients with active NCC were offered a combination
of dexamethasone and anthelmintic treatment in an inpatient setting and, according to the res-
olution of their symptoms a re-scan free of charge.
Study site
The study was carried out in Mtandaza community in Katete district of the Eastern province of
Zambia (Fig 1). The Mtandaza Rural Health Center (RHC) provides health care in this com-
munity with a catchment population of approximately 20000. The people in this area practice
subsistence agriculture raising animals like cattle, goats, pigs and chickens and growing crops
like maize, groundnuts, bananas and cotton. Their homes are of adobe, have few sanitary facili-
ties with hand pumps being the source of water for most villages. Pigs are commonly bought
and sold among villagers and also to intermediary traders from nearby towns. Since sanitation
is poor, pigs have access to the feces in nearby bushes that are used as latrines by the villagers.
The district of Katete was chosen because endemicity of human and porcine T. solium cysti-
cercosis has been demonstrated during previous studies [16, 18]. The rural community was
selected because of free-range pig keeping, absence of active ongoing sanitation programs,
reports of people with epilepsy (PWE), and the common observation of cysticerci in slaugh-
tered pigs. Furthermore, the RHC had shown willingness to collaborate with this study.
Study design and recruitment of people with epilepsy
This was a single-center, cross-sectional and community-based study. In August 2012, the
study began with the screening of all inhabitants of villages within a 7 km radius from the
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Mtandaza RHC. Local health workers, after undergoing basic questionnaire administration
training, used a standardized screening questionnaire modified and adapted by Birbeck and
Kalichi [19] to identify people with possible epilepsy (see S1 File). The screening questionnaire
was administered door-to-door to any individual that lived in the study area and was willing to
participate.
Altogether, 4443 individuals were screened (Fig 2). Due to financial restriction the number
of computed tomography (CT) scans had to be limited to 50. Therefore, the recruitment started
with those people with the highest number of positive answers to the screening questions 1–8
and a negative answer in question nine. Finally, all people with a minimum of four positive
answers and one with three positive answers, giving a total of 101 individuals, were invited for
further examinations at the RHC. Twenty-five individuals were either not available for exami-
nation or refused to participate in the study. After written informed consent, we examined 76
individuals with suspected epilepsy. Twenty individuals dropped out because they had no epi-
lepsy or they withdrew their consent (see also Table 1).
Fig 1. Map of Zambia showing the study area in Katete district of the Eastern province.
doi:10.1371/journal.pntd.0003972.g001
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The 56 identified PWE provided a detailed medical history, underwent neurological exami-
nation and provided blood and stool samples for the immunological diagnosis of cysticercosis
Fig 2. Draft of the study design.
doi:10.1371/journal.pntd.0003972.g002
Table 1. Reasons for exclusion and number of individuals excluded from the study.
Reason for exclusion Number
Only febrile seizures 6
No epileptic seizures 2
Alcohol provoked seizures 2
Other provoked seizures 2
Syncope 3
Single provoked seizure 2
Psychosis 1
Withdrawal of consent 2
Total 20
doi:10.1371/journal.pntd.0003972.t001
Prevalence of Neurocysticercosis and Epilepsy in Zambia
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003972 August 18, 2015 5 / 15
and taeniosis, respectively (Fig 2). Epilepsy was diagnosed according to a classification for
resource poor settings, which is in agreement with the definitions of epilepsy by the Interna-
tional League against Epilepsy, but was adapted to local circumstances. The four major diag-
nostic groups were “Generalized seizures within specific age range”, “Generalized seizures
outside specific age range”, “Generalized seizures with diffuse brain damage” and “Generalized
seizures with focal signs”. The first two groups were distinguished by the age at onset of epi-
lepsy being either within or outside the age span of six to 25 years [20]. Fifty-one patients were
diagnosed with active epilepsy (PWAE), which was defined that the patient had had seizures
within the last two years or had been on antiepileptic medication, while five had inactive epi-
lepsy (PWIE) and did not fulfill the criteria mentioned before. The PWAE were transported
480 km to Lusaka and examined for lesions compatible with NCC by CT scanning of the brain
at the public Levy Mwanawasa General Hospital.
Sample collection and analyses
About 5 ml of blood were collected into sterile plain blood collecting tubes and allowed to clot.
Serum was extracted from all the blood samples by first allowing them to stand at 4°C over-
night and then centrifuging at 3000g for 15 minutes. The supernatant (serum) was then ali-
quoted into 1.8 ml vials and stored at -20°C until use. Submitted stool samples were placed in
10% formalin and stored until use. All the samples were analyzed in the Cysticercosis Working
Group for Eastern and Southern Africa Reference Centre for Cysticercosis at the School of Vet-
erinary Medicine at the University of Zambia in Lusaka.
The serum samples were tested for circulating cysticercal antigens using the monoclonal
antibody based B158/B60 antigen enzyme linked immunosorbent assay (sero-Ag-ELISA) as
described by Dorny et al. [21]. To determine the cutoff, the optical density (OD) of each serum
sample was compared with a series of eight reference negative human serum samples at a prob-
ability level of p< 0.001 [21]. The serum samples were also tested for specific antibodies
against cysticercosis using a commercial kit, Immunetics (Immunetics Inc., Boston, Massachu-
setts, USA). The assay was performed according to the manufacturer’s instructions. In brief,
the assay is an enzyme linked immunoelectrotransfer blot (EITB), which uses seven purified T.
solium antigens (diagnostic bands being Gp50, Gp42-39, Gp24, Gp21, Gp18, Gp14 and Gp13,
whereby Gp stands for glycoprotein and the number is the molecular weight of each antigen
expressed in kilodaltons). Reactions to any one or more of the bands are considered positive.
The stool samples were examined for copro-antigens using the polyclonal antibody based
ELISA (copro-Ag-ELISA) as described by Allan et al. [22] with slight modifications [15]. To
determine the test result, the OD of each stool sample was compared with the mean of a series
of eight reference Taenia negative stool samples plus three standard deviations (cut-off).
Performance of neuroimaging
Of the 51 PWAE, 49 (two refused) underwent CT examination at the Levy Mwanawasa Gen-
eral Hospital in Lusaka. The CT machine used was a Neusoft helical multi-slice scanner (Neu-
soft Medical Systems, Shenyang, China). The thickness of slices for the whole scan was 5 mm.
Intravenous contrast medium was not applied. A set of 101 consecutive cerebral CT scans were
also obtained from the hospital data base. These were from patients presenting for CT scanning
for various indications; however no further clinical information was available. Therefore, we
selected those scans (n = 40) that had a clear pathology assuming that this was the reason for
the performance of the CT scan and searched for NCC related pathologies on the CT scan
images. The scans were checked by two people independently, a neuroradiologist (KS) and a
neurologist (JB). In case of disagreement, the scans were discussed until a consensus was
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achieved. CT based diagnosis of NCC was divided into three groups: definite NCC lesions, lesions
highly suggestive of, and those compatible with NCC. Definite NCC lesions were cystic lesions
showing the scolex while those without a visible scolex, multiple and parenchymal brain calcifica-
tions were categorized as lesions highly suggestive of NCC [23]. Compatible cases were those
with any other pathology that could be caused by NCC, such as hydrocephalus [24, 25], and
those with single calcifications in brain parenchyma [26]. NCC was diagnosed as being either
active for any cystic lesions or inactive for only parenchymal calcifications [27, 28].
Diagnosis of NCC
Diagnosis of NCC was based on the Del Brutto diagnostic criteria [23]. Different diagnostic find-
ings are stratified into absolute, major and minor criteria. The combination of these criteria results
in a diagnosis of “Definitive NCC”, “Probable NCC” and “NoNCC” [23]. All our participants had
an epidemiological criterion, because they lived in an area endemic for T. solium taeniosis/cysticer-
cosis and all PWE had a minor criterion, because they had a clinical manifestation suggestive of
NCC. Additional to the Del Brutto criteria, we also used sero-Ag-ELISA as a major criterion as
proposed by Gabriël et al. [29]. Both diagnostic classifications are presented in the result section.
Statistical analysis
Data from the screening questionnaire and all further examinations was entered into a Micro-
soft Excel spreadsheet (double entry and review, according to Good Data Practice (GDP) and
analyzed with R (3.1.0) (http://www.r-project.org/). The statistical test used is mentioned in the
text. The significance level was set to 0.05. In the analysis of age differences, cases with
unknown age are excluded from the analysis. For the diagnosis of NCC missing values for
minor, major and absolute criteria are set to negative.
Results
Due to limited funding the number of PWE selected for CT scan had to be limited to a maxi-
mum of 50 individuals. One patient refused to go to Lusaka, therefore we conducted 49 CT
scans. Another limitation is the selection of people with high scores in the screening question-
naire, which might have led to a selection bias of PWE. More details about the limitations of
this study are mentioned in the discussion.
Demographic data
Of the 51 PWAE, 24 (47.1%) were females. For the five PWIE, one (20.0%) was female. In the
group of 40 CT control scans, 20 (50.0%) were women. There was no significant difference in
gender distribution among the three groups (Fisher’s exact test, p = 0.552).
The mean age with standard deviation of the 56 people with active epilepsy and inactive epi-
lepsy was 32.3 ± 15.3 and 28.8 ± 20.4 years, respectively. The mean age of the patients from the
CT control scans was 41.4 ± 20.9 years. There was a significant difference in age among the
three groups (ANOVA, p = 0.048). A Scheffe-Post-Hoc-Test revealed a borderline difference
between CT controls and PWAE (p = 0.070).
Diagnosis of epilepsy
After history taking and neurological examination of the 56 patients, epilepsy was diagnosed
and classified as shown in Table 2. The majority of PWE had clinically generalized seizures
with about one third (17/56) having “Generalized seizures within specific age range” and a
quarter (14/56) with “Generalized seizures outside specific age range”.
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Laboratory tests
Of the 56 PWE, 39.3% (22/56) had T. solium cysticercosis antibodies while 23.2% (13/56) had
circulating cysticercus antigens. Fifty-four PWE provided a stool sample and 14.8% (8/54)
were positive for taeniosis on copro-Ag ELISA (Table 3). The diagnostic tests results according
to activity of epilepsy and the CT scan result are presented in Table 3. A list with age, gender,
the clinical diagnosis of epilepsy, the descriptive diagnosis of the CT scan, number of active
and inactive NCC lesions, serological results and the diagnosis of NCC for every participant is
shown in the supplement material S1 Table. There were no significant differences comparing
results of the laboratory tests with the result of the classification of NCC lesions in CT scanning
(Fisher test; EITB: p = 0.452, Ag-ELISA: p = 0.100, copro-Ag ELISA: p = 0.542).
Diagnosis of NCC based on computed tomography results
CT scanning was performed on 49 (96.1%) of the 51 PWAE. Lesions compatible with NCC
were found in 12.2% (6/49), lesions highly suggestive of NCC in 24.5% (12/49) and definite
Table 2. Diagnosis of type of epilepsy after neurological examination.
Type of seizure Number
Generalized seizures within speciﬁc age range 17
Generalized seizures outside speciﬁc age range 14
Generalized seizures with focal signs 11
Generalized seizures with diffuse brain damage 7
Complex partial seizures 2
Inactive epilepsy 5
Total 56
doi:10.1371/journal.pntd.0003972.t002
Table 3. Diagnostic test results according to activity of epilepsy and CT scan results.
Diagnostic test
Serum EITB Serum Ag-ELISA Copro-Ag ELISA
Epilepsy activity N No. +ve (%) No. +ve (%) No. +ve (%)
Inactive 5 3 (60.0) 2 (40.0) 1 (20.0)
Active 51* 19 (37.3) 11 (21.6) 7 (14.3)
Totals 56** 22 (39.3) 13 (23.2) 8 (14.8)
NCC result on CT scan of PWAE
No NCC lesion 29 9 (31.0) 5 (17.2) 3 (10.3)
Compatible 6*** 1 (16.7) 1 (16.7) 1(20.0)
Highly suggestive 12 6 (50.0) 2 (16.7) 3 (25.0)
Deﬁnite 2 1 (50.0) 2 (100) 0 (0.0)
Total 49**** 17 (34.7) 10 (20.4) 7 (14.6)
*For Copro-Ag ELISA n = 49
** For Copro-Ag ELISA total n = 54
*** For Copro-Ag ELISA n = 5
**** For Copro-Ag ELISA total n = 48
PWAE. . . People with active epilepsy, PWIE. . . People with inactive epilepsy, NCC . . . Neurocysticercosis, CT. . . Computed tomography, EITB. . . Enzyme
linked immunoelectrotransfer blot to detect cysticercus antibodies in serum, Ag-ELISA. . . Detection test for cysticercus antigens in serum, Copro-Ag
ELISA. . . Detection test for antigens in stool to diagnose taeniosis
doi:10.1371/journal.pntd.0003972.t003
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NCC lesions in 4.1% (2/49) of CT scans of PWAE. This compares to 15.0% (6/40), 2.5% (1/40)
and 0.0% (0/40), respectively, in the control CT scans. The difference between the two groups
was statistically significant (Fisher’s exact test, p< 0.001). A detailed description of all CT
scans results can be found in supplement material (S1 Table).
Two people with active epilepsy had a calcification in themasseter muscle visible on CT
scan, which could be interpreted as cysticercosis outside the central nervous system (CNS).
However, Del Brutto defines “cysticercosis outside CNS”, which is a minor criterion, as multi-
ple calcification in thigh or calf muscles [23]. Therefore, we did not consider these calcifications
as “cysticercosis outside CNS”.
Diagnosis of NCC according to the Del Brutto criteria
Combining CT scan and serology EITB results, 15.7% (8/51) of PWAE were diagnosed with
definitive and additionally 35.3% (18/51) with probable NCC as described by Del Brutto [23]
(Table 4). Of the five PWIE, three (60%) were diagnosed with probable NCC. Combining
definitive and probable NCC, this resulted in an overall NCC prevalence of 51.8% (29/56)
among PWE. 31.0% (9/29) of people with probable or definitive NCC had no NCC lesion on
CT scan.
Diagnosis of NCC according to the adapted criteria proposed by Gabriël
et al.
Adding the sero-Ag-ELISA results as a major diagnostic criteria, as proposed by Gabriël et al.
[29], 25.5% (13/51) and 31.4% (16/51) of PWAE were diagnosed with definitive and probable
NCC, respectively (Table 4). Of the five PWIE, two (40.0%) were diagnosed with definitive
NCC and another one (20.0%) with probable NCC. The overall NCC prevalence in PWE was
therefore 57.1% (32/56). 34.4% (11/32) of people with probable or definitive NCC had no NCC
lesions on CT scan.
Associations of NCC with age, gender and clinical diagnosis of epilepsy
Combining probable and definitive NCC into a dichotomous variable, there were no significant
differences in terms of gender and age at examination between people with and those without
NCC (gender: Fisher test, Gabriël et al.: p = 0.280, Del Brutto: p = 0.788, age at examination:
T-test, Gabriël et al.: p = 0.817, Del Brutto: p = 0.666). Also, the age at first seizure was not
Table 4. Diagnosis of neurocysticercosis according to Del Brutto (2012) and Gabriël et al. (2012) diagnostic criteria.
NCC diagnosis according to Del Brutto, (2012, without
Antigen-ELISA in serum as major criterion)
NCC diagnosis according to Gabriël et al., (2012, with
using Antigen-ELISA in serum as major criterion)
No NCC Probable NCC Deﬁnitive NCC No NCC Probable NCC Deﬁnitive NCC
Group n (%) n (%) n (%) n (%) n (%) n (%)
PWAE* 25 (49.0) 18 (35.3) 8 (15.7) 22 (43.1) 16 (31.4) 13 (25.5)
PWIE** 2 (40.0) 3 (60.0) 0 (0.0) 2 (40.0) 1 (20.0) 2 (40)
CT Controls# 40 (100) 0 (0.0) 0 (0.0) 40 (100) 0 (0.0) 0 (0.0)
Total 67 (69.8) 21 (21.9) 8 (8.3) 64 (66.7) 17 (17.7) 15 (15.6)
*n = 49
** n = 5, no CT scan results available
# n = 40, only CT scan results available
PWAE. . . People with active epilepsy, PWIE. . . People with inactive epilepsy, NCC . . . Neurocysticercosis, CT. . . Computed tomography
doi:10.1371/journal.pntd.0003972.t004
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significantly different between the two groups (T-test, Gabriël et al.: p = 0.894, Del Brutto:
p = 0.705). There was no significant association between the clinical diagnosis of epilepsy
according to Winkler et al. [20] and NCC diagnosis (Fisher test, Del Brutto: p = 0.265, Gabriël
et al.: p = 0.298). The age, gender and clinical diagnosis of epilepsy are shown in Table 5.
Discussion
The results of this study, indicating NCC as the single most important cause of epilepsy in the
study area, add to the body of knowledge on the endemicity of T. solium in Zambia, besides the
reports on the parasite in pigs [17, 18, 30] and more recently in humans [15, 16]. This will
therefore contribute to the burden assessment of this important, yet neglected parasite.
The prevalence of NCC among PWE reported in this study is one of the highest reported so far
in the sub-Saharan African region. At a prevalence of 57.1%, based on the inclusion of the sero-
Ag-ELISA test result, as proposed by Gabriël et al. [29], it ranks higher than what has been reported
in the pooled world estimate of 29% [7]. It also ranks higher than those reported elsewhere in the
world. In Latin America, a recent meta-analysis of epilepsy and NCC revealed an NCC proportion
of 32.3% among PWE [31] with the highest being 47% reported in a CT based study in Guatemala
[32]. The estimates in Africa range from 11% in Burkina Faso [7] to 37% in the Eastern Cape Prov-
ince of South Africa [33] with Tanzania reporting a prevalence of 16.5% [26].
Table 5. The age at examination and at first seizure, gender and clinical diagnosis of epilepsy is shown according to the Del Brutto and Gabriël
et al. diagnostic criteria.
NCC diagnosis Age at
examination
Age at ﬁrst
seizure
Gender Clinical diagnosis of epilepsy
Mean ± SD
in years
Mean ± SD
in years
F M Generalized
seizures
within
speciﬁc age
range
Generalized
seizures
outside
speciﬁc age
range
Generalized
seizures with
diffuse brain
damage
Generalized
seizures
with focal
signs
Complex
partial
seizures
Inactive
epilepsy
NCC
according
to Gabriël
et al., 2012
No
NCC
32.6 ± 15.3 17.0 ± 16.3 N 13 11 4 7 4 5 2 2
% 54.2 45.8 16.7 29.2 16.7 20.8 8.3 8.3
Def./
prob.
31.6 ± 16.0 16.4 ± 15.9 N 12 20 13 7 3 6 0 3
% 37.5 62.5 40.6 21.9 9.4 18.8 0.0 9.4
NCC
according
to Del
Brutto
2012
No
NCC
31.0 ± 15.1 15.8 ± 15.8 N 13 14 5 8 5 5 2 2
% 48.1 51.9 18.5 29.6 18.5 18.5 7.4 7.4
Def./
prob.
32.9 ± 16.3 17.4 ± 16.2 N 12 17 12 6 2 6 0 3
% 41.4 58.6 41.4 20.7 6.9 20.7 0.0 10.3
NCC . . . Neurocysticercosis, F. . .Female, M. . . Male, SD. . . Standard deviation; Generalized seizures within speciﬁc age range: primary generalized
seizures that start within a speciﬁc age range (mainly between 6 and 25 years when most of the idiopathic generalized epilepsies start); Generalized
seizures outside speciﬁc age range: primary generalized seizures that lie outside the speciﬁc age range of most of the idiopathic generalized epilepsies,
but have no focal start and no clinical signs of brain damage; Generalized seizures with diffuse brain damage: secondary generalized seizures with no
clear focal start but clinically obvious diffuse brain damage; Generalized seizures with focal signs: secondary generalized seizures with a focal start or
clear unilateral seizures but without major brain damage; Complex partial seizures: focal seizures with loss of consciousness (see also [20])
doi:10.1371/journal.pntd.0003972.t005
Prevalence of Neurocysticercosis and Epilepsy in Zambia
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003972 August 18, 2015 10 / 15
The mean age of PWAE with NCC in this study (32.9 years) is comparable to that reported
elsewhere. Blocher et al. [26] reported a mean age of 32.5 years in a study in Tanzania. Though
we had a limited sample size, the lack of association between NCC and age may point towards
NCC being a cause of epilepsy in both the elderly and the young. Similarly, the age at first sei-
zure was not significantly different between PWE with and without NCC, which is in line with
results from Tanzania [26]. There was also no significant difference in gender distribution in
our study cohort. This was similar to findings by Blocher et al. [26] in Tanzania who also did
not find a significant difference regarding gender.
A prevalence of copro-Ag-ELISA positives of 14.8% among the 54 PWE may indicate a pos-
sible autoinfection with T. solium eggs that could lead to NCC. Adult tapeworm carriers are
not only a risk for cysticercosis to themselves, in light of poor personal hygiene, but also to
other members of their households and the community. In Mexico, Garcia-Garcia et al. dem-
onstrated that the presence of tapeworm carriers in households is the main risk factor attrib-
uted to human cysticercosis [34]. These carriers intermittently shed proglottids and/or
substantial numbers of infective eggs in their feces, thereby exposing the people in their envi-
ronment to cysticercosis for example due to the unhygienic preparation and serving of food
[35]. With the prevailing low standards of sanitation and personal hygiene, infection and re-
infection is therefore a high possibility, hence the increased levels of cysticercosis in people liv-
ing in the area. At almost 60%, we have highlighted the importance of NCC as the most impor-
tant single cause of epilepsy in our study area. This may also apply to other areas of Eastern
and Southern provinces of Zambia, where factors for the maintenance of the parasite have
been reported and high levels of environmental contamination were highlighted by the elevated
porcine cysticercosis [18, 30] and human taeniosis/cysticercosis prevalence estimates [15, 16].
A study by Mwape et al. [16] reported a high taeniosis prevalence of 11.9% in an area in Katete
district, indicating a substantial number of adult tapeworm carriers with the potential to result
in marked environmental contamination with the taeniid eggs. The study also reported an
average cysticercosis sero-prevalence of 13.1% (sero-Ag) and 35.4% (sero-antibody(Ab)) dur-
ing the study period. Incidence rates of 6300 (sero-Ag, per 100000 persons-year) and 23600
(sero-Ab, per 100000 persons-year) were also determined. The sero-reversion rates recorded
were 44% and 38.7% for sero-Ag and sero-Ab, respectively, over the whole period [16]. The
study by Mwape et al. showed the dynamic nature of T. solium infections and that many of the
people at risk become (re)infected due to the substantial environmental contamination, with a
high number turning sero-negative within a year after infection. With increased levels of (re)
infection rates, the possibility of NCC becomes very likely. These results, though from a differ-
ent part of the district, may explain the high prevalence of NCC in PWAE in addition to the
prevailing risk factors for T. solium transmission in the study area of the current study.
The sero-prevalence of cysticercosis antibodies of 39.3% in our population of PWE is similar
compared to the 35.4% (mean) reported in a population not suffering from epilepsy in another
part of the district [15]. The prevalence of anticysticercal antibodies in PWE in our study was
similar to the one reported in a study in South Africa (41.7%) [33], but is higher than that
reported from Tanzania (15.9%) [4]. Concerning cysticercal antigens, 23.2% in our population
with epilepsy compared to 13.1% in a population without epilepsy [16].
Currently, the only published criteria for the diagnosis of neurocysticercosis, which are used
in epidemiological studies, are those of Del Brutto [23]. These criteria basically combine results
of neuroimaging (CT and/or Magnetic Resonance Imaging) and serological diagnostic tools
(circulating cysticercal antigen in cerebrospinal fluid and specific antibody detection in serum/
cerebrospinal fluid). Gabriël et al. suggested an adaptation of these criteria by using sero-Ag-
ELISA as a major criterion [29]. Diagnostic criteria are important in order to compare preva-
lence data from different countries; however they have limitations for the diagnosis of
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individual patients. The aim of this paper was not to discuss the different diagnostic criteria of
neurocysticercosis. However, it is important to note that 34.4% (11/32) of those with a diagno-
sis of “Probable NCC” or “Definitive NCC” according to Gabriël et al. [29] and 31.0% (9/29)
according to Del Brutto [23] have no NCC lesion on CT. Whether these patients have cysticer-
cosis outside the central nervous system, the serological test was false positive or the NCC
lesions were missed because of lack of sensitivity of a CT scan cannot be resolved. The latter
has been observed in six of seven sero-Ag-ELISA positive patients with calcified NCC lesions
but without viable cysts on CT scan [36].
The majority of NCC lesions were calcifications, which may support the hypothesis that
mainly calcified NCC lesions are epileptogenic [27] and seizures usually develop at a later stage
of the disease. When reporting low numbers of viable cysts the probably lower sensitivity of CT
scan for cystic lesions has to be considered.
Two people had calcifications outside the CNS, more specifically in the masseter muscles.
However, the Del Brutto criterion “Cysticercosis outside the CNS” does not include this in its
description, but rather mentions multiple ‘cigar-shaped’ calcifications in the thigh and calf
muscles [23]. He states that, in endemic regions, a patient may have systemic cysticercosis and
neurological manifestations due to an unrelated cause. Though this is true, we nevertheless
propose that evidence on either CT scan or plain X-ray films of extra CNS cysticercal lesions in
the muscles of the head/thorax be included in the minor criterion “Cysticercosis outside the
CNS”.
Although the data presented in this study is indeed valuable in analyzing the importance of
NCC in PWE, there are some limitations. The selection of people with the highest number of
positive answers in the screening questionnaire could have resulted in a bias towards more
severe cases of epilepsy, i.e. with more generalized tonic-clonic seizures compared to a typical
epilepsy population. We cannot rule out that there are different etiologies in different types of
severity of epilepsy. Additionally, focal seizures without secondary generalization are rarely
diagnosed as epileptic seizures in resource poor countries. This might have led to an underesti-
mation of people with focal seizures in our study population. Because focal seizures have usu-
ally an underlying cause, we assume that in people with only focal seizures NCC lesions might
be even more common, but we cannot prove this hypothesis with our data.
Unfortunately, there was no clinical information about the consecutive hospital cerebral CT
scans available. Therefore, some patients in the consecutive scans could have had epilepsy as
well and can therefore not be considered a true control group. By selecting controls with patho-
logic lesions other than NCC, the related symptoms of which were probably the reason for the
scan, we tried to lower the probability of including PWE in the CT controls. However, we still
think, it is valuable to get more information about the prevalence of NCC in a set of CT scans,
because it might help to compare the prevalence of NCC among countries at a larger scale and
therefore we have included the information of all 101 consecutive CT scans in the supplement
material (S1 Table). In sub-Saharan Africa many countries have very few neuroimaging facili-
ties. Consecutive images of these centers might be used as a sentinel to evaluate the NCC preva-
lence in a country. In a similar study in Tanzania, Winkler et al. reported a CT based
prevalence of 1% of definite NCC in controls without epilepsy [4]. In the current study, the CT
scans were performed only once and without application of contrast medium. As a conse-
quence ring enhancing lesions and resolution of lesions after treatment, which are part of the
Del Brutto criteria, could not be gathered. Similarly, a fundoscopic examination to visualize
subretinal cysts, an X-ray of calf or thigh muscles or histology was not available, which might
have led to a slight underestimation of the prevalence of NCC among PWE. In addition, in the
people with the consecutive CT scans no serological tests were available, which could have also
resulted in an underestimation of NCC in this group.
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In conclusion, our study results of almost 60% of PWE suffering from additional NCC
should be taken seriously, despite the study limitations. This is one of the highest prevalence
rates based on neuroimaging reported in sub-Saharan Africa and entails the need for the com-
mencement of concerted efforts towards the control of T. solium in endemic areas of Zambia.
The findings also highlight the importance of NCC as a differential diagnosis for patients pre-
senting with epileptic seizures not only in rural areas but also in other areas of. The present
study suggests that NCC seems the most important secondary cause of epilepsy, a cause that is
preventable and even eradicable [37] and therefore much more attention should be directed to
its control in T. solium taeniosis/(neuro)cysticercosis endemic countries like Zambia.
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